Loading ETF profile…

The series, under normal circumstances, invests at least 95% of its net assets in American Depositary Receipts (“ADRs”) of the Novo Nordisk A/S (B Shares) (the “Company”). The series will not invest directly in the company. The fund is non-diversified.
بيانات التوزيع القطاعي غير متوفرة لهذا الصندوق بعد.
| Symbol | Name | Weight | Market Value |
|---|---|---|---|
| NVO | Novo Nordisk A/S (B Shares) | 97.00% | $4.07M |
| — | Cash (US$) | 3.00% | $126.14K |